EWA
GILD icon

Etesian Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Etesian Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.43M Sell
10,279
-1,082
-10% -$152K 0.46% 53
2025
Q4 		$1.39M Hold
11,361
– – 0.44% 56
2025
Q3 		$1.26M Sell
11,361
-172
-1% -$19.6K 0.42% 63
2025
Q2 		$1.28M Sell
11,533
-811
-7% -$86.3K 0.48% 58
2025
Q1 		$1.38M Sell
12,344
-364
-3% -$37.6K 0.6% 51
2024
Q4 		$1.17M Sell
12,708
-2,860
-18% -$258K 0.52% 60
2024
Q3 		$1.31M Sell
15,568
-1,629
-9% -$124K 0.59% 52
2024
Q2 		$1.18M Sell
17,197
-536
-3% -$35.8K 0.66% 49
2024
Q1 		$1.3M Sell
17,733
-585
-3% -$45K 0.75% 48
2023
Q4 		$1.49M Buy
18,318
+128
+0.7% +$9.96K 0.89% 37
2023
Q3 		$1.36M Sell
18,190
-357
-2% -$27.5K 0.92% 38
2023
Q2 		$1.43M Sell
18,547
-591
-3% -$47.1K 0.93% 36
2023
Q1 		$1.59M Sell
19,138
-332
-2% -$27.5K 1.06% 34
2022
Q4 		$1.67M Buy
+19,470
New +$1.54M 1.22% 31

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Etesian Wealth Advisors's GILD Position: Q1 2026 in Review

Etesian Wealth Advisors reduced its Gilead Sciences (GILD) stake by 9.5% in Q1 2026, selling an estimated $152K and leaving 10,279 shares worth $1.43M. The position accounts for 0.46% of the portfolio, ranked #53.

Etesian Wealth Advisors first reported a position in GILD in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.67M in Q4 2022. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Etesian Wealth Advisors held 10,279 shares of Gilead Sciences worth $1.43M as of Q1 2026.
  • Etesian Wealth Advisors sold 1,082 Gilead Sciences shares in Q1 2026, an estimated $152K.
  • Gilead Sciences made up 0.46% of Etesian Wealth Advisors's portfolio in Q1 2026, its #53 holding.
  • Etesian Wealth Advisors first reported a position in Gilead Sciences in Q4 2022 and has held it in 14 quarters since.
  • Etesian Wealth Advisors's Gilead Sciences position peaked at $1.67M in Q4 2022.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Etesian Wealth Advisors's 13F filing for Q1 2026, filed 23 Apr 2026.